Greg brings over 25 years of public and private company leadership experience

Philadelphia, PA, August 1, 2024 – NodThera, a leading clinical-stage biotech delivering a paradigm shift in the treatment of chronic inflammatory diseases through selective modulation of the NLRP3 inflammasome, today announces the appointment of Greg Chow as Chief Financial and Business Officer (CFBO), effective immediately.

Greg is an experienced executive with over 25 years of corporate finance, capital markets, investment banking, financial accounting, drug development operations, and business development experience. Over the course of his career, he has led major financing rounds for both public and private companies, as well as supported operations and administrative functions.

Greg joins NodThera from Freenome Holdings, where he served as Chief Financial Officer (CFO) and helped successfully execute the company’s recent $254 million Series F financing round. Prior to Freenome, Greg was CFO at Frontier Medicines, where he led its Series B and C fundraising rounds and headed up Alliance Management for its global, multi-year collaboration with Abbvie.  His leadership across Frontier’s business operations was instrumental in helping the company transition from a discovery-stage to clinical-stage organization. Greg gained significant public company experience as Executive Vice President and CFO at Aptose Biosciences (Nasdaq: APTO), overseeing the company’s dual listing on the Nasdaq and Toronto stock exchanges in addition to successfully raising over $225 million and attracting multiple new shareholders.

Prior to his time as an industry executive, Greg spent 14 years in investment banking as Managing Director and Director of Private Placements at Wedbush Securities and in senior roles at RBC Capital Markets and Wells Fargo Securities. Greg holds an MBA in Finance from the Wharton School at the University of Pennsylvania and a BA in Business Economics from the University of California, Santa Barbara. He is a Certified Public Accountant (inactive) in the state of California.

Daniel Swisher, Chief Executive Officer of NodThera, said: “Greg’s financial experience and extensive track record of long-term value creation for both private and public biotechs will be invaluable as NodThera continues to execute its strategy and evolves into a mature, high-value, clinical-stage company. I look forward to working closely with him as part of our executive team. Greg will be a key strategic partner as we continue to unlock the broad potential and maximum value of our highly differentiated brain-penetrant NLRP3 inflammasome inhibitors in the treatment of chronic inflammatory diseases. On behalf of the whole team, I would like to wish him a very warm welcome to NodThera.”

Greg Chow, Chief Financial Officer of NodThera, added: “I am incredibly excited to join NodThera at such a pivotal time in its development. The potential to modulate inflammation for the treatment of chronic diseases presents a significant opportunity to impact patients’ lives in a meaningful way. I look forward to being immersed in one of the most exciting and rapidly evolving therapeutic categories in biotech today. With a highly accomplished team, positive progression of lead candidate NT-0796 and upcoming Phase II studies in obesity, cardiovascular and Parkinson’s disease, NodThera is well positioned in its current trajectory with some important inflection points on the near-term horizon. I

am eager to bring my capital markets, operations, and business development experience to NodThera and look forward to partnering with Dan, the Board of Directors, and the wider team.”

For more information about NodThera please contact:

NodThera
Tel: +44 (0) 1223 608130
Email: info@nodthera.com

ICR Consilium
Amber Fennell, David Daley, Sukaina Virji
Tel: +44 (0)20 3709 5700
Email: nodthera@consilium-comms.com

About NodThera

NodThera is a leading clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases. Led by an experienced management team, NodThera is combining a deep understanding of NLRP3 inhibition, pharmaceutical neuroscience expertise and precision molecular chemistry. Its two lead clinical candidates are oral, small molecule NLRP3 inflammasome inhibitors, which have demonstrated differentiated, potentially best-in-class clinical profiles with significant anti-inflammatory effects and the ability to penetrate different areas of the brain, offering distinct opportunities to treat multiple indications. The Company is backed by top-tier investors including 5AM Ventures, Blue Owl Capital, Epidarex Capital, F-Prime Capital, Novo Holdings, Sanofi Ventures and Sofinnova Partners. NodThera is headquartered in Philadelphia, Pennsylvania, with additional operations in Cambridge, UK and Seattle, WA. Learn more at www.nodthera.com or follow the Company on LinkedIn.

Dan Jablonsky will lead the rocket propulsion startup Ursa Major

WASHINGTON — Ursa Major, a rocket propulsion company, announced Aug. 1 that Dan Jablonsky, former chief executive of Maxar Technologies, has been appointed as its new CEO effective Aug. 5.

Jablonsky succeeds Ursa Major co-founder Joe Laurienti, who has led the company since its inception nine years ago. Ursa Major specializes in developing and manufacturing rocket engines for space launch, hypersonic, and solid rocket motor applications.

The leadership change comes as Ursa Major seeks to expand its reach in the space and defense sectors. The company completed a successful flight of its Hadley small rocket engine in March and announced plans for a new research and development facility in Youngstown, Ohio.

“To continue advancing Ursa Major’s work in space, hypersonics, and solid rocket motors, now is the right time for the company to bring in a new leader with the expertise and track record to successfully guide the company into further reaches of scale and impact,” Laurienti said in a statement.

Jablonsky brings significant industry experience to the role, having previously led the space technology firm Maxar Technologies through its take-private acquisition by Advent International.

“I have followed Ursa Major’s many successes over the past nine years and am confident in the impact that its advanced technology and manufacturing approaches will have on the space and defense communities for years to come,” said Jablonsky. “I look forward to enhancing America’s national security and expanding U.S. critical space and defense infrastructure capabilities.”

Laurienti revealed that he had initially planned to bring Jablonsky on as an advisor before deciding he would be a better fit for the CEO position.

Ursa Major is headquartered in Berthoud, Colorado. With private and government funding the company developed the Hadley engine, which produces 5,000 pounds of thrust, and the Ripley engine, designed for medium-launch markets with 50,000 pounds of thrust. It’s also working on the Arroway engine, with 200,000 pounds of thrust, and the Draper engine, aimed at hypersonic and defense applications.

Jablonsky will lead the rocket propulsion startup Ursa Major

CHICAGO, IL – July 23, 2024 – Adams Street Partners, LLC, a private markets investment firm with more than $59 billion in assets under management (“Adams Street”), today announced the appointment of Jim Walker as Partner & Global Head of Wealth. Walker, who has served as Partner & Chief Operating Officer at Adams Street, will focus on leading Adams Street’s growth in the wealth management space, with an emphasis on developing and scaling of products and services designed to service financial advisors and their clients. Adams Street also launched a new website – pws.adamsstreetpartners.com – dedicated to sharing insights, news, and resources for financial advisors and wealth platforms.

“Jim is a natural fit for this role as a senior leader with deep investment acumen and significant operational experience. His extensive background in wealth management will accelerate our growth in private wealth,” said Jeffrey Diehl, Managing Partner & Head of Investments at Adams Street. “Adams Street’s private markets investment solutions can provide wealth advisors compelling opportunities to further help their clients grow and protect their wealth.”

“Our Private Wealth platform benefits from Adams Street’s more than 50 years of experience,” said Walker. “There is significant demand from advisors and their clients for quality private markets investments. Adams Street can provide access, institutional quality origination, and portfolio construction in ways that are accessible to private wealth clients.”

Walker takes on this new position after nearly seven years as Adams Street’s COO. Before joining Adams Street, Walker held a range of senior leadership positions at Morgan Stanley, Credit Suisse, and Merrill Lynch.

Walker’s COO responsibilities will be split between his new role and Partner & Chief Financial Officer Michael Kurlander.

About Adams Street Private Wealth Solutions

Adams Street Partners provides wealth managers and financial advisors access to private markets knowledge and investment solutions designed to help their clients grow and protect wealth. The firm was founded over 50 years ago and manages $59 billion for clients across private equity and venture capital funds, secondary, growth equity, buyout and venture co-investments, and private credit strategies. Adams Street has offices in Austin, Beijing, Boston, Chicago, London, Menlo Park, Munich, New York, Seoul, Singapore, Sydney, and Tokyo.
pws.adamsstreetpartners.com

This information is not investment advice or an offer or sale of any security or investment product or investment advice. Offerings are made only pursuant to a private offering memorandum containing important information. Statements are made as of the date of this release, and there is no implication that the information contained herein is correct as of any time subsequent to such date. Past performance is not a guarantee of future results. Adams Street Partners, LLC is a US investment adviser governed by applicable US laws, which differ from laws in other jurisdictions.

Media Inquiries:
Rich Myers / Rachel Goun
Profile Advisors
+1 347 774 1125
adamsstreet@profileadvisors.com

Flexpoint Ford (“Flexpoint”), a private equity investment firm specializing in the financial services and healthcare sectors, is pleased to announce that Josh Tamaroff has joined the healthcare team as a Managing Director in the firm’s New York office. In his new role, Mr. Tamaroff will focus on originating, evaluating and executing investment opportunities in the healthcare sector and will work closely with the team to help further drive the firm’s efforts in the space.

With nearly 15 years of experience in healthcare private equity, Mr. Tamaroff is a seasoned investor and brings a wealth of knowledge to Flexpoint. Most recently, he served as a Partner at Avista Capital Partners (“Avista”). During his tenure at Avista, he worked on significant investments across the pharmaceutical and medical technology sectors and associated value chains, including previously serving as a Director of Cosette Pharmaceuticals, GCM Holding Corporation, OmniAb, Inc. (NASDAQ: OABI), Organogenesis, Inc. (NASDAQ: ORGO), Probo Medical, Solmetex, Terrats Medical, and United BioSource Corporation. Earlier in his career, Mr. Tamaroff worked as an Analyst in the Leveraged Finance Group at Lehman Brothers and Barclays Capital. He received an MBA from The Wharton School at the University of Pennsylvania, where he was a Palmer Scholar, and a BS from Cornell University.

“Josh’s extensive experience in healthcare private equity is highly complementary to our industry expertise at Flexpoint as we continue to build our group of talented investment professionals,” said Don Edwards, CEO of Flexpoint. “We are excited he is joining the Flexpoint team.”

Chris Ackerman, Managing Partner of Flexpoint added, “Josh’s deep industry knowledge and unique experience investing in pharmaceutical and medical technology services companies will help broaden the reach of our healthcare team, and we welcome him to the firm.”

“I am excited to join a team where I can leverage my extensive background in healthcare investing to further enhance the firm’s already impressive private equity platform, and I look forward to contributing to the firm’s promising trajectory,” said Mr. Tamaroff. He added, “Flexpoint’s partnership approach and expertise in scaling companies align well with my passion for fostering growth and transformative change in the healthcare sector.”

QUINCY, Mass. July 10, 2024. IntelyCare, the healthcare industry’s most comprehensive nurse talent platform, today announced that it has appointed Matthew Levesque as the new Chief Executive Officer and member of the Board of Directors. A veteran healthcare executive known for scaling mission-driven organizations, Levesque will lead the expansion of IntelyCare’s platform into a total talent solution, offering full- and part-time hiring, as well as temporary staffing for all types of nursing professionals in acute and post-acute settings.

Healthcare systems and facilities across the U.S. continue to grapple with a historic shortage of nursing staff coupled with a rapidly aging population and evolving federal and state regulations.

“The core of what we do at IntelyCare is putting nurses by the bedside where they are most needed. While we are known for staffing in skilled nursing settings — where our nursing team is rated highest for quality by facilities — it’s time to bring that expertise to more nurses in more diverse care settings,” said Levesque. “Our goal is not just to fill shifts. We are committed to providing a total talent solution that promotes quality care and nursing career development, while simultaneously meeting our partner clients’ unique staffing and hiring needs.”

Levesque brings nearly three decades of healthcare IT and two-sided marketplace experience to IntelyCare. He was previously the President and COO of Groups Recover Together, a national leader in value-based care for opioid addiction treatment. Prior to that, he served as CEO of connectRN, a provider of shift-based nurse labor. He also held key roles at athenahealth over a 12-year tenure, including Senior Vice President of Technology Enabled Services, during which the company grew from $100M to $1.3B in revenue. Earlier in his career, Levesque worked in operating roles at priceline.com and healthcare insurers Oxford Health Plans and Harvard Pilgrim Health Care.

Throughout his time in healthcare, Levesque has been passionate about building sustainable businesses with life-saving missions. His extensive experience uniquely positions him to scale businesses with multiple product lines and stakeholders amidst evolving regulatory challenges – all while preserving the highest standard of care.

“The demands of both nurses and healthcare facilities have shifted post-pandemic. To ensure care continuity, staffing models and the technology and services that support them must also evolve,” said David Coppins, Executive Chairman of the Board. “Matt has spent his career integrating technology with the needs of businesses and caregivers. He is the right person to lead the next evolution of IntelyCare.”

About IntelyCare

IntelyCare is the most comprehensive healthcare talent platform, enabling care settings of all kinds to promote their unique value and work opportunities to the largest community of qualified nurses. By allowing nurses to construct the optimal workforce situation to fulfill their career and lifestyle goals, and enabling facilities to create the optimal workforce mix, IntelyCare helps overcome the healthcare labor crisis and elevate care for all.

Wendel announces the appointment of Laure Delabeye as Director of Human Resources and Services for the
Wendel Group. In this role, she will be in charge of Human Resources, General Resources and IT services.

Biography of Laure Delabeye
After graduating from EFAP (École des nouveaux métiers de la communication) and IGS
(Institut de Gestion Sociale), Laure Delabeye, 54 years old, worked over 25 years as
Human Resources Director in French and international environments, mainly in the
Finance and Insurance sectors.

Before joining Wendel, Laure spent 14 years as Human Resources Manager in AXA
Group operating entities, supporting their transformation. Laure then joined the American
bank JP Morgan as HR Director for France, before extending her responsibilities to Spain
and Portugal. For 7 years, she acquired expertise in leading teams in multicultural and sensitive contexts, and
dealt in particular with the impacts of Brexit from an HR point of view on a European level. From 2019 to 2021,
Laure was Global Head of Human Resources for Natixis Investment Banking.

In 2021, Laure made a turning point in her career by becoming a certified coach (HEC Global International
Executive coaching, ICF accredited). She set up Oyat Coachsulting to support senior executives facing new
challenges.

Expands Senior Leadership Team with Hires of Francesca Merlino as Chief Commercial Officer and Joseph Wittmann as General Manager

NEW YORK—June 3, 2024—Hudson Yards Experiences (“HYE”), operator of Edge (the highest indoor/outdoor sky deck in the Western Hemisphere), CityClimb (the world’s highest aerial adventure course) and Peak (restaurant, bar and private event business), today announced the appointment of longtime entertainment, media and sports executive, Andrew Lustgarten, to the new role of Executive Chairman of HYE.

Joining HYE’s newly created senior leadership team headed by Mr. Lustgarten are Francesca Merlino as Chief Commercial Officer and Joseph Wittmann as General Manager. The new appointments bolster HYE’s strong operating capabilities and team, positioning HYE’s portfolio of marquee New York City attractions for continued growth and success.

“HYE presents a tremendous opportunity to build upon a portfolio of already distinguished New York brands,” said Mr. Lustgarten. “Edge offers a unique experiential destination that we will continue to position at the forefront of New York City’s live entertainment market through fresh experiences and partnerships that make it a must-visit destination for locals and visitors alike.”

“Andy’s proven track record of building businesses, driving synergies across multi-venue operating portfolios, and orchestrating inventive consumer activations uniquely position him to lead Edge’s multifaceted business,” said Blaine MacDougald, Partner and Co-Head of KKR’s Strategic Investments Group. “We are delighted to unveil HYE’s newly created senior leadership comprised of executives behind some of the world’s most successful entertainment properties.”

“Hudson Yards’ success is a testament to the visionary talent driving every aspect of the neighborhood, and our commitment to continually investing in forward-thinking leaders like Andy,” said Mike Gilbane, Senior Vice President, Related Companies. “Edge is one of New York City’s most recognizable experiences and we look forward to leveraging Andy’s unparalleled entertainment expertise, alongside our impressive group of new and existing team members, as we continue to grow the business.”

Biographies of HYE’s new senior leadership team:

Andrew Lustgarten, Executive Chairman

Mr. Lustgarten is an Executive Advisor to KKR focused on sports and entertainment investment opportunities and was most recently CEO and President of Madison Square Garden Sports Corp. and President of Madison Square Garden Entertainment Corp. where he oversaw the overall business strategy and day-to-day operations for the Companies’ wide range of entertainment franchises, including the New York Knicks, New York Rangers, and Radio City Rockettes as well as world-class venues Madison Square Garden, Radio City Music Hall, The Hulu Theater, The Beacon Theatre, The Chicago Theater, The LA Forum and the development of first-of-its-kind, entertainment venue, Sphere. He was also responsible for leading efforts to identify new initiatives and investments to advance the Companies’ business, such as driving numerous landmark marketing partnership deals across MSG’s portfolio, overseeing MSG’s acquisition of Tao Hospitality Group and Hakkasan and investments in DraftKings and Townsquare Media.

Mr. Lustgarten remains a member of the MSG Sports board of directors and is a member of Parella Motorsports Holdings board of directors.  Prior to joining Madison Square Garden’s family of companies, Mr. Lustgarten held senior positions at the NBA and Cablevision. He also previously served on the board of governors for the NBA and the NHL, the board of directors of Tao Group Hospitality, Boston Calling Music Festival, Tribeca Film Festival and Counter Logic Gaming. He is also Chairman of the Board of the Lustgarten Foundation, the world’s largest private funder of pancreatic cancer research.

Francesca Merlino, Chief Commercial Officer

Mrs. Merlino will join HYE in July from Hornblower Group where she serves as Chief Marketing Officer and is responsible for engaging over 22 million visitors annually across a global portfolio of travel and experience offerings. At Hornblower, she oversees the organization’s marketing strategy, communications, brand, digital, revenue optimization, and analytics teams. Before Hornblower, she spent seven years at The Madison Square Garden Company overseeing media planning and marketing for a diverse array of entertainment and sporting franchises including the Radio City Rockettes, the New York Knicks, and the New York Rangers, as well as over 250 events annually across MSG’s iconic New York and Chicago venues. She spent the first six years of her career in marketing at the Solomon R. Guggenheim Museum. She is a graduate of Fordham University.

Joseph Wittmann, General Manager

Mr. Wittman has over 20 years of experience directing some of the U.S.’s most iconic venues and attractions, including over a decade at The Madison Square Garden Company where he managed renowned performance venues including the 3,600 seat Chicago Theatre and 2,900 seat Beacon Theatre. He spent nearly five years at The Shed, a multi-disciplinary non-profit cultural intuition at Hudson Yards, where he oversaw facilities and operations.

About Hudson Yards Experiences:

Hudson Yards Experiences operates Edge, CityClimb and Peak on behalf of a joint venture ownership group led by KKR and Related.

Edge is the highest indoor/outdoor sky deck in the Western Hemisphere offering unparalleled 360-degree views of New York City’s iconic skyline. Rising 1,131 feet in the air and extending out 65 feet from the 100th floor of 30 Hudson Yards, the outdoor viewing area features a thrilling glass-floor, angled glass walls and outdoor skyline steps from the 100th to 101st floors. The venue’s cantilevered terrace is an iconic part of the New York’s skyline and is featured regularly in film and media worldwide. For more information, please visit: https://www.edgenyc.com/.

CityClimb is the highest open-air building ascent in the world. The aerial adventure course allows guests, secured by harness and escorted by certified guides, to scale the outside of a skyscraper more than 1,200 feet above ground, then lean out and look down from the highest outdoor platform in New York City. For more information, please visit: https://www.edgenyc.com/en/cityclimb.

Peak’s roughly 10,000 square foot restaurant, bar, café and private event space is located on the 101st Floor overlooking Edge. For more information, please visit: https://www.peaknyc.com/.

Media Contacts:

KKR

Miles Radcliffe-Trenner
(212) 750-8300
media@kkr.com

Related Companies

Kathleen Anne Corless
(212) 801-1000
communications@related.com

DOWNLOAD PDF

CapMan Growth appoints Timo Larjomaa as Senior Advisor

Timo Larjomaa has been appointed as Senior Advisor for the CapMan Growth team. Timo has long experience in international asset management from Intermediate Capital Group (ICG), where he worked for many years, most recently as Managing Director, Head of Nordics. Timo currently works as a private investor and is a co-investor in CapMan Growth’s companies Silmäasema and Fennoa.

“Timo brings us valuable know-how related to international business, larger-scale business operations and especially software business and healthcare services. We have already had the pleasure of working with him on several joint projects,” says CapMan Growth’s Managing Partner Antti Kummu.

CapMan Growth is the leading Finnish growth investor making significant minority investments in entrepreneur-led growth companies with revenues ranging between €10–200 million. We offer entrepreneurs an alternative to selling the majority of their business by facilitating a partial exit while also supporting growth and internationalisation. We have been part of building companies such as Coronaria, Cloud2, Digital Workforce, Fennoa, Fluido, Neural DSP, Picosun, Sofigate, Silmäasema and Unikie.

For more information, please contact:

Antti Kummu, Managing Partner, CapMan Growth, +358 50 432 4486

About CapMan

CapMan is a leading Nordic private asset expert with an active approach to value creation and €5.7 billion in assets under management. As one of the private equity pioneers in the Nordics we have developed hundreds of companies and assets creating significant value for over three decades. Our objective is to provide attractive returns and innovative solutions to investors by enabling change across our portfolio companies. An example of this is greenhouse gas reduction targets that we have set under the Science Based Targets initiative in line with the 1.5°C scenario and our commitment to net-zero GHG emissions by 2040. We have a broad presence in the unlisted market through our local and specialised teams. Our investment strategies cover real estate and infrastructure assets, natural capital and minority and majority investments in portfolio companies. We also provide wealth management solutions. Our service business includes procurement services. Altogether, CapMan employs around 200 professionals in Helsinki, Jyväskylä, Stockholm, Copenhagen, Oslo, London and Luxembourg. We are listed on Nasdaq Helsinki since 2001. www.capman.com

NEW YORK – May 7, 2024 – Blackstone (NYSE:BX) today announced the appointment of Philip Sherrill as Global Head of Insurance. In his new role, Mr. Sherrill will focus on growing the firm’s insurance platform globally, working closely with Gilles Dellaert, Global Head of Blackstone Credit & Insurance.

Blackstone’s insurance platform has tripled in size since 2020, recently surpassing $200 billion in assets under management. The platform leverages the firm’s scale and breadth to serve Blackstone’s insurance clients, to drive stronger long-term performance, and, ultimately to meet the needs of more policyholders.

Gilles Dellaert, Global Head of Blackstone Credit & Insurance, said: “We are very pleased to welcome Phil to Blackstone as Global Head of Insurance. Our credit and insurance business is experiencing enormous growth momentum, and we see a significant opportunity set ahead of us. Phil’s experience and expertise will be instrumental in taking our platform’s growth to the next level.”

Philip Sherrill said: “Blackstone has an unparalleled platform and an exceptional record of client service, putting it in a unique position to deliver value to insurance companies. I am privileged to become a part of this team and I look forward to joining Blackstone.”

Mr. Sherrill was previously Chief Strategy Officer at Global Atlantic Financial Group, where, for more than a decade, he led corporate strategy, mergers and acquisitions, capital raising, and other strategic initiatives across business lines, serving on the firm’s Management Committee, Investment Committee, Operating Committee, Risk Committee, and Capital Committee, among other leadership roles. Mr. Sherrill worked at Goldman Sachs prior to Global Atlantic’s separation from Goldman, and holds an A.B. in Social Studies from Harvard College.

About Blackstone
Blackstone is the world’s largest alternative asset manager. We seek to deliver compelling returns for institutional and individual investors by strengthening the companies in which we invest. Our more than $1 trillion in assets under management include global investment strategies focused on real estate, private equity, infrastructure, life sciences, growth equity, credit, real assets, secondaries and hedge funds. Further information is available at www.blackstone.com. Follow @blackstone on LinkedIn, X (Twitter), and Instagram.

Contact
Felix Lettau
+44 (0) 7587 020 020
Felix.Lettau@Blackstone.com